Background Image
Table of Contents Table of Contents
Previous Page  13 / 78 Next Page
Information
Show Menu
Previous Page 13 / 78 Next Page
Page Background

NCCN Guidelines for Patients

®

Soft Tissue Sarcoma, Version 1.2014

11

1

Sarcoma basics

Drug treatments

Chart 1.1 Drug treatments for sarcoma

Generic (chemical) name

Brand name (sold as)

Type of drug

Bevacizumab

Avastin

®

Targeted therapy

Celecoxib

Celebrex

®

Targeted therapy

Crizotinib

Xalkori

®

Targeted therapy

Dacarbazine

DTIC-Dome

®

Chemotherapy

Dasatinib

Sprycel

®

Targeted therapy

Docetaxel

Taxotere

®

Chemotherapy

Doxorubicin

Chemotherapy

Doxorubicin hydrochloride, injection

Doxil

®

Chemotherapy

Epirubicin hydrochloride

Ellence

®

Chemotherapy

Everolimus

Afinitor

®

Chemotherapy

Gemcitabine hydrochloride

Gemzar

®

Chemotherapy

Ifosfamide

Chemotherapy

Imatinib mesylate

Gleevec

®

Targeted therapy

Interferon alfa 2b, recombinant

Intron

®

A

Immunotherapy

Mesna

Mesnex

®

Injection

Chemotherapy

Methotrexate

Chemotherapy

Nilotinib

Tasigna

®

Targeted therapy

Paclitaxel

Taxol

®

Chemotherapy

Pazopanib

Votrient

®

Targeted therapy

Regorafenib

Stivarga

®

Targeted therapy

Sorafenib tosylate

Nexavar

®

Targeted therapy

Sirolimus

Rapamune

®

Chemotherapy

Sulindac

Clinoril

®

Targeted therapy

Sunitinib malate

Sutent

®

Targeted therapy

Tamoxifen citrate

Targeted therapy

Temozolomide

Temodar

®

Chemotherapy

Toremifene citrate

Fareston

®

Targeted therapy

Vinblastine sulfate

Chemotherapy

Vinorelbine tartrate

Navelbine

®

Chemotherapy